Shawn Demehri
Massachusetts General Hospital

Last Updated On 4/12/2022 8:38:58 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: ROME Therapeutics
Recipient: You
Company: Gerson Lehman Group (GLG)
Recipient: You
Company: Guidepoint Global, LLC
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
No Relationships to Disclose

Patents, Royalties, Other Intellectual Property
Please describe: I am co-inventors on a filed patent for the use of interleukin 33 inhibition for the treatment of cancer, fibrosis and inflammation (PCT/US21/40725). This patent is licensed to DermBiont
Recipient: You

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
No Relationships to Disclose